FNY Investment Advisers’s Aratana Therapeutics, Inc. PETX Stock Holding History

FNY Investment Advisers’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-300	Closed	-$1K	–	1328
2019 Q2	$1K	Buy	+300	New	+$1.35K	﹤0.01%	923
2019 Q1	–	Sell	-500	Closed	-$3K	–	1075
2018 Q4	$3K	Sell	500 -200	-29%	-$1.22K	﹤0.01%	571
2018 Q3	$4K	Hold	700	–	–	﹤0.01%	652
2018 Q2	$2K	Buy	+700	New	+$3.53K	﹤0.01%	868

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

FNY Investment Advisers's PETX Position: Q3 2019 in Review

FNY Investment Advisers sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 300 shares — an estimated $1K sold.

FNY Investment Advisers first reported a position in PETX in Q2 2018 and held it in 4 quarters. The position peaked at $4K in Q3 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

FNY Investment Advisers reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
FNY Investment Advisers sold 300 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1K.
FNY Investment Advisers first reported a position in Aratana Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
FNY Investment Advisers's Aratana Therapeutics, Inc. position peaked at $4K in Q3 2018.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.